Failure of amygdalin to arrest B16 melanoma and BW5147 AKR leukemia

Parenteral amygdalin was found to be ineffective in C57BL/6 mice with B16 melanoma and in AKR mice with BW5147 lymphatic leukemia, in doses ranging from 50 to 5000 mg/kg.

Saved in:
Bibliographic Details
Published in:Cancer research (Chicago, Ill.) Ill.), 1976-06, Vol.36 (6), p.2102-2107
Main Authors: Hill, 2nd, G J, Shine, T E, Hill, H Z, Miller, C
Format: Article
Language:English
Subjects:
Amygdalin - pharmacology
Amygdalin - therapeutic use
Animals
Female
Leukemia, Experimental - drug therapy
Leukemia, Experimental - etiology
Melanoma - drug therapy
Melanoma - etiology
Melphalan - therapeutic use
Mice
Mice, Inbred AKR
Mice, Inbred C57BL
Neoplasms, Experimental - drug therapy
Neoplasms, Experimental - etiology
Nitriles - therapeutic use
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Parenteral amygdalin was found to be ineffective in C57BL/6 mice with B16 melanoma and in AKR mice with BW5147 lymphatic leukemia, in doses ranging from 50 to 5000 mg/kg.
ISSN:0008-5472